Human Neutrophil Peptide 1 vs Kalata B1 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human Neutrophil Peptide 1 (HNP-1) is the most abundant alpha-defensin in human neutrophil granules, where it constitutes up to 30% of total protein content. Alpha-defensins HNP-1, -2, -3, and -4 are the human versions of the ancestral defensin family....
Calculate Human Neutrophil Peptide 1 dose →Kalata B1 is the prototype cyclotide - a cyclic peptide with a head-to-tail backbone cyclization and three disulfide bonds forming a cystine knot topology. Isolated from the plant Oldenlandia affinis, which is traditionally used in Africa to accelerate childbirth (uterotonic use)...
Calculate Kalata B1 dose →| Parameter | Human Neutrophil Peptide 1 | Kalata B1 |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Preclinical |
| Half-Life | Hours (in tissues) | Hours (resistant to all proteases) |
| Typical Dose | N/A | N/A |
| Frequency | N/A | N/A |
| Route | Endogenous (secreted by neutrophils) / Research only | Research only (oral stability under study) |
| FDA Status | Not approved | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.